A clinical study to evaluate the immunomodulatory support and overall health benefits of CUQ1720 and AK-CQAB-0520 in subjects with allergic symptoms

Not Applicable

• Registration Number: CTRI/2021/01/030355
• Lead Sponsor: Akay Natural Ingredients Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Subjects categorized as AR according to international guideline of American Academy of Allergy Asthma and Immunology

2. History of allergic rhinitis (persistent or seasonal) symptoms for at least two consecutive years.

3. No antibiotics use within 1 month prior to entering the study or during the study

4. If female of childbearing age, willing to use an acceptable form of birth control measure, should be stable for past 3 months prior to baseline and throughout the Study

5. Must be willing and able to give informed consent and comply with the study procedures

Exclusion Criteria

1. Asthmatic subjects who required long term inhaled or systemic corticosteroids within the previous 30 days

2. Subjects with nasal polyps and chronic respiratory tract infections

3. Subjects having symptoms of viral infection, including COVID-19 infection

4. Subjects with deteriorating health status at the time of enrolment, rapid weight loss, terminal disease, significant chronic disease (e.g., chronic diarrhoea, gastro-intestinal diseases, irritable bowel syndrome)

5. History of Recent blood donation, Immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection)

6. Concomitant medication/supplement which could affect the study

7. Any contraindication to blood sampling

8. Pregnant and lactating women

9. Subjects allergic to herbal products, nuts or any component of the study product

10. Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study

11. Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified